Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized CRISPR/cas9 systems and methods for gene editing in stem cells

Optimized CRISPR/cas9 systems and methods for gene editing in stem cells

US Patent 11390884 · Granted Jul 19, 2022

Estimated economic value: $6,574,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for the treatment of hemoglobinopathies2024
CRISPR/RNA-guided nuclease systems and methods2024
CRISPR/Cas-related methods and compositions for improving transplantation2024
Systems and methods for the treatment of hemoglobinopathies2023
CA2 compositions and methods for tunable regulation2021